Contract Services Methods Development

Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies

Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs) Merck now one of industry’s largest manufacturer...

 June 24, 2022 | News

WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes

WuXi Biologics offers global partners high-efficiency and high-quality manufacturing services for clinical trial and commercial supply by increasing pre-...

 June 06, 2022 | News

Biomerics Announces Image Guided Intervention (IGI) Division

The goal of image-guided intervention systems is to increase the clinician's spatial navigation abilities while reducing the mental burden associated with ...

 May 03, 2022 | News

Merck Advances BioProcessing Capabilities with Acquisition of MAST® Platform from Lonza

Merck to become first company to offer a fully integrated ecosystem for advanced process technologies Brings biopharmaceutical industry closer to digita...

 April 14, 2022 | News

WuXi Biologics Achieved Record Growth and Profitability in 2021

WuXi Biologics (Cayman) Inc. ("WuXi Biologics" or "the Group," stock code: 2269.HK), a global Contract Research, Development and Manufacturing Organization...

 March 23, 2022 | News

I Peace triples GMP cell manufacturing by expanding CDMO facility

The facility's expansion, designed to conform to GMP standard, is now almost complete and is expected to start manufacturing cGMP grade cells in April this...

 March 15, 2022 | News

Lonza Leads Market with Large and HLA-Typed CD34+ Cell Lots for Efficient Humanized Mouse Model Development

CD34+ cell lots in a range of sizes also now available with high-resolution HLA information, eliminating the need for cumbersome and costly HLA screening...

 March 08, 2022 | News

HCmed, Formosa Lab, and Formosa Pharma Signed MoU to Form a Global CDMO for Inhalation Treatment Drugs

By integrating HCmed's vibrating mesh nebulizers, Formosa Laboratories' drug development and manufacturing capabilities, and Formosa Pharmaceuticals' APNT ...

 March 07, 2022 | News

WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at its Wuxi City Site

The PAI focused on the drug product manufacturing of an innovative drug for one of WuXi STA’s partners. During a 5-day remote inspection from Novembe...

 March 04, 2022 | News

Vetter’s extraordinary performance sweeps the board at the 2022 CMO Leadership Awards

Vetter’s high-level performance further substantiates its dedicated performance in customer-critical services Results affirm the approach, vision,...

 March 03, 2022 | News

Why are Regulations & Guidelines necessary for Drug Development & Manufacturing?

What Led To Drug Regulation? To make sure that a drug product is safe for consumption, it is imperative that the process of drug development and manufactu...

 March 01, 2022 | Opinion

WuXi STA Wins 2022 CMO Leadership Awards in All Six Core Categories

For the 2022 CMO Leadership Awards, Life Science Leader Magazine teamed up with Industry Standard Research (ISR) to conduct the Contract Manufacturing Qual...

 February 11, 2022 | News

National Cancer Center Japan and GenScript ProBio Enter Research Collaboration Agreement for a Plasmid & Lentiviral vector CMC development

The project initialized by National Cancer Center Research Institute. Under the agreement, National Cancer Center and GenScript Biotech will collaborate on...

 February 07, 2022 | News

CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma

Dr. Michael Quirmbach, Chief Executive Officer & President of CordenPharma said, "We welcome the three sites and their employees as new members to...

 February 02, 2022 | News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in